Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: A case control study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Shu, Chin Chung ^a   Wang, Jann Tay ^a   Lee, Chih Hsin ^b   Wang, Jann Yuan ^a   Lee, Li Na ^a   Yu, Chong Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; RETROSPECTIVE STUDY; SPUTUM CULTURE; SPUTUM SMEAR; CASE CONTROL STUDY; CYTOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROSCOPY; PATHOLOGY; RECURRENT DISEASE; SPUTUM; TAIWAN; TEACHING HOSPITAL; THORAX RADIOGRAPHY; TUBERCULOSIS;

AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; RECURRENCE; RETROSPECTIVE STUDIES; SPUTUM; TAIWAN; TUBERCULOSIS;

EID: 77952299399     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-48     Document Type: Article

References (26)

1. Kuo SHS, Yi SW, Ting L, et al. Taiwan Tuberculosis Control Report 2007. 2008, Taipei: Centers for Disease Control, Department of Health, R.O.C (Taiwan), 4.
2. Harling G, Ehrlich R, Myer L. The social epidemiology of tuberculosis in South Africa: a multi-level analysis. Soc Sci Med 2008, 66(2):492-505. 10.1016/j.socscimed.2007.08.026, 17920743.
3. Shimouchi A. Tuberculosis problems in the Asia-Pacific region. Respirology 2001, 6(1):75-78. 10.1046/j.1440-1843.2001.00301.x, 11264768.
4. Centers for Disease Control and Prevention (CDC) Trends in tuberculosis--United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58(10):249-253. Centers for Disease Control and Prevention (CDC).
5. Albert RK, Iseman M, Sbarbaro JA, Stage A, Pierson DJ. Monitoring patients with tuberculosis for failure during and after treatment. Am Rev Respir Dis 1976, 114(6):1051-1060.
6. Lu D, Heeren B, Dunne WM. Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 2002, 118(4):542-545. 10.1309/65KN-2M7E-7MNN-X0TA, 12375641.
7. Wang JY, Lee LN, Hsu HL, Hsueh PR, Luh KT. Performance assessment of the DR. MTBC Screen assay and the BD ProbeTec ET system for direct detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 2006, 44(3):716-719. 10.1128/JCM.44.3.716-719.2006, 1393081, 16517844.
8. Wang JY, Lee LN, Chou CS, et al. Performance Assessment of a Nested-PCR Assay (the RAPID BAP-MTB) and the BD ProbeTec ET System for Detection of Mycobacterium tuberculosis in Clinical Specimens. J Clin Microbiol 2004, 42(10):4599-4603. 10.1128/JCM.42.10.4599-4603.2004, 522346, 15472315.
9. Pfyffer VV, Christina Gutiérrez M, Brown-Elliott BA, Wallace RJ. Myobacterium. Manual of Clinical Microbiology 2007, Washington, DC: American Society for Microbiology, Patrick R, Murray EJB, JH Jorgensen, MA Pfaller, Marie L Landry, 6.
10. American Thoracic Society Centers for Disease Control and Prevention Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1376-1395. American Thoracic Society Centers for Disease Control and Prevention.
11. Yu MC, Wu MH, Jou R. Extensively drug-resistant tuberculosis, Taiwan. Emerg Infect Dis 2008, 14(5):849-850. 10.3201/eid1405.071398, 2600264, 18439381.
12. Centers for Disease Control and Prevention (CDC) Treatment of tuberculosis. MMWR Recomm Rep 2003, 52(RR-11):1-77. Centers for Disease Control and Prevention (CDC).
13. Luh KT, . (ed) Taiwan guidelines for TB diangosis and treatment. 2008, Taipei: Center for Disease Control, Executive Yuan, Taiwan (R.O.C.), 3, (ed).
14. Zhao FZ, Levy MH, Wen S. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis 1997, 1(6):570-572.
15. Salaniponi FM, Christensen JJ, Gausi F, Kwanjana JJ, Harries AD. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1999, 3(11):1047-1048.
16. Huang CT, Tsai YJ, Shu CC, et al. Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. Respir Med 2009 2009, 103(10):1484-91.
17. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175(4):367-416. 10.1164/rccm.200604-571ST, 17277290.
18. Koh WJ, Yu CM, Suh GY, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 2006, 10(9):1001-1007.
19. Wendel KA, Alwood KS, Gachuhi R, et al. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001, 120(1):193-197. 10.1378/chest.120.1.193, 11451837.
20. Shu CC, Lee CH, Wang JY, et al. Non-tuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 2008, 34(12):2194-2201. 10.1007/s00134-008-1221-6, 18648768.
21. Lai CC, Tan CK, Huang YT, et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis 2008, 47(7):e57-63. 10.1086/591702, 18715157.
22. Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 2005, 25(3):564-569. 10.1183/09031936.05.00111304, 15738303.
23. Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis 1996, 77(2):124-129. 10.1016/S0962-8479(96)90026-X, 8762846.
24. Lienhardt C, Manneh K, Bouchier V, et al. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998, 2(9):712-718.
25. Wang JY, Hsueh PR, Wang SK, et al. Disseminated tuberculosis: a 10-year experience in a medical center. Medicine 2007, 86(1):39-46. 10.1097/MD.0b013e318030b605, 17220754.
26. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Respirology 2009, 14(7):1012-1019. 10.1111/j.1440-1843.2009.01598.x, 19659516.